006890.KS KSC
Taekyung Chemical Co., Ltd.
1W: -1.7%
1M: -7.3%
3M: -11.6%
YTD: -38.5%
1Y: -51.8%
3Y: -65.8%
5Y: -70.7%
₩4,855.00 ($3.61)
+10.00 (+0.21%)
Weekly Expected Move ±2.4%
₩4625
₩4740
₩4855
₩4970
₩5085
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$61.3B
-13.7% ▼
5Y CAGR: +5.4%
Gross Profit
$15.1B
-46.0% ▼
5Y CAGR: -3.3%
Operating Income
$2.1B
-84.9% ▼
5Y CAGR: -23.1%
Net Income
$6.5B
-48.5% ▼
5Y CAGR: -3.4%
EPS (Diluted)
$560.62
-49.7% ▼
5Y CAGR: -3.8%
EBITDA
$4.6B
-74.1% ▼
5Y CAGR: -18.0%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $54.1B | $59.6B | $70.7B | $71.1B | $61.3B |
| YoY Growth | +14.9% | +10.3% | +18.7% | +0.5% | -13.7% |
| Cost of Revenue | $30.9B | $36.3B | $39.1B | $43.1B | $46.3B |
| Gross Profit | $23.2B | $23.3B | $31.6B | $28.0B | $15.1B |
| Gross Margin | 42.9% | 39.1% | 44.7% | 39.3% | 24.6% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $6.1B | $7.0B | $8.0B | $7.8B | $0 |
| Operating Expenses | $11.1B | $12.9B | $13.7B | $14.3B | $13.0B |
| Operating Income | $12.1B | $10.4B | $17.9B | $13.7B | $2.1B |
| Operating Margin | 22.4% | 17.4% | 25.3% | 19.3% | 3.4% |
| Interest Expense | $12M | $8M | $10M | $18M | $889M |
| Income Before Tax | $14.0B | $12.0B | $21.7B | $15.1B | $7.1B |
| Tax Expense | $3.1B | $3.3B | $4.3B | $2.4B | $585M |
| Net Income | $10.9B | $8.9B | $17.4B | $12.6B | $6.5B |
| Net Margin | 20.2% | 14.9% | 24.6% | 17.7% | 10.6% |
| EPS (Diluted) | $963.01 | $782.40 | $1536.93 | $1113.57 | $560.62 |
| EBITDA | $15.9B | $14.3B | $24.2B | $17.6B | $4.6B |
| Shares Outstanding | 11M | 11M | 11M | 11M | 11M |